Symbol Name ID |
Dbt
dihydrolipoamide branched chain transacylase E2 MGI:105386 |
Darker colors indicate more annotations |
Human Phenotypes | Increased serum pyruvate |
Hyperisoleucinemia |
Hyperleucinemia |
Elevated circulating branched chain amino acid concentration |
Elevated circulating L-alloisoleucine concentration |
Increased CSF isoleucine concentration |
Increased CSF leucine concentration |
Increased CSF valine concentration |
Elevated circulating hepatic transaminase concentration |
Reduced branched-chain alpha-keto acid dehydrogenase activity in cultured fibroblasts |
Hypoglycemia |
Ketoacidosis |
Lactic acidosis |
Metabolic acidosis |
Cerebral edema |
Positive 2,4-dinitrophenylhydrazine urine test |
Increased level of hippuric acid in urine |
Ketosis |
Disease(s) Associated with DBT | ||||||||||||||||||
maple syrup urine disease |
Mouse Phenotypes | abnormal circulating amino acid level |
decreased circulating alanine level |
decreased circulating glutamic acid level |
decreased circulating glutamine level |
aminoaciduria |
|
Availability | Mouse Genotype | |||||
Dbttm1Geh/Dbttm1Geh |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/30/2024 MGI 6.23 |
|
|